Critically ill patients are at risk of stress-induced upper gastrointestinal bleeding. Now, a global trial led by McMaster University researchers confirms that a widely available drug does prevent upper gastrointestinal bleeding.
Tag: Bleeding
STOP THE BLEED® Instructor Licensing Program Now Available
A new licensing program has been released to expand access to vital life-saving training for individuals and communities. The STOP THE BLEED® Instructor Licensing Program is designed for professionals eager to teach STOP THE BLEED® techniques to their communities and organizations. Registration for this free program takes only minutes via an online application, enabling swift involvement while supporting approved instructors.
An aspirin a day? Poll of older adults suggests some who take it may be following outdated advice
One in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll shows. But many people aged 50 to 80 who said they take aspirin may not need to because hey don’t have a history of cardiovascular disease.
Annual Medicare spending could increase by $2 to $5 billion if Medicare expands coverage for dementia drug lecanemab
The anti-dementia medication lecanemab and its ancillary costs could add $2 billion to $5 billion in annual Medicare spending if the Centers for Medicare and Medicaid Services (CMS) revise their coverage decision. Currently, the medication is covered only for patients who are enrolled in clinical trials.
![](https://sciencenewsnet.in/wp-content/uploads/2023/03/64074c74bff91_12.png)
Chicago Cubs Become the First MLB Team to Install American College of Surgeons STOP THE BLEED® Kits
The Chicago Cubs have taken an important step to keep fans, staff, and players safe in case a bleeding emergency occurs by installing trauma kits at Wrigley Field.
New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR
Major bleeding reduced in patients having non-cardiac surgery
The drug tested, tranexamic acid (TXA), was given to patients at risk of bleeding or vascular complications. The study found that TXA did not increase deep vein clotting known as VTE, heart attack, non-hemorrhagic stroke, or other major vascular complication in the 30 days after surgery.
In the study, half of 9,535 patients in 22 countries were randomly assigned TXA, half placebo. Patients were 45 years or older (average age 69 years); 44% of them were female.
Cost, bleeding cited as major reasons for not taking newer anti-coagulant as prescribed
People who are prescribed the anti-coagulant apixaban cite six major reasons for failing to adhere to their prescriptions, including cost and potential bleeding.
Subset of COVID-19 Patients Have Increased Bleeding Risk
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
![](https://sciencenewsnet.in/wp-content/uploads/2020/10/2020_CC_ABST_StoptheBleed1200x630Final.jpg)
STOP THE BLEED training has saved lives from Sierra Leone to Connecticut
Two studies presented at the American College of Surgeons (ACS) Clinical Congress 2020 provide evidence that STOP THE BLEED training is effective and has made a lifesaving difference around the world.